查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1088294

骨科生物製品市场:各产品，各用途，各终端用户，各地区，趋势分析，竞争市场占有率及预测(2018年～2028年)

Orthobiologics Market, By Product, By Application, By End User, By Region (North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa Trend Analysis, Competitive Market Share & Forecast, 2018-2028
出版日期: | 出版商: Blueweave Consulting | 英文 189 Pages | 商品交期: 2-3个工作天内

价格

全球骨科生物製品的市场规模在2021年估算为62亿美金。今后在2022年～2028年间预计将以5.20％的年复合成长率扩大，到2028年终将达到约88亿美元。

本报告提供全球骨科生物製品市场相关调查，提供市场概要，以及各产品，各用途，各终端用户，各地区趋势，竞争情形，及加入此市场的主要企业简介等资讯。

目录

第1章 调查架构

第2章 调查手法

第3章 摘要整理

第4章 全球骨科生物製品市场洞察

  • 产业的价值链分析
  • DROC分析
  • 技术形势/最近的开发
  • 法律规范
  • 波特的五力分析

第5章 全球骨科生物製品市场概要

  • 市场规模与预测，2018年～2028年
  • 市场占有率与预测
    • 各产品
      • 脱灰骨矩阵(DBM)
      • 同类移植
      • 骨形成蛋白(BMP)
      • 关节内粘稠补充疗法产品
      • 人工骨替代物
      • 其他
    • 各用途
      • 骨关节炎及变性关节炎
      • 脊椎融合手术
      • 骨折修復
      • 软组织损伤
      • 颚颜面及牙科用
    • 各终端用户
      • 医院及门诊中心
      • 研究学术机构
      • 牙科医院
    • 各地区
      • 北美
      • 欧洲
      • 亚太地区
      • 南美
      • 中东·非洲

第6章 北美的骨科生物製品市场

第7章 欧洲的骨科生物製品市场

第8章 亚太地区的骨科生物製品市场

第9章 南美的骨科生物製品市场

第10章 中东·非洲的骨科生物製品市场

第11章 竞争情形

第12章 COVID-19对全球骨科生物製品市场的影响

第13章 企业简介(企业概要，财务矩阵，竞争情形，主要人员，主要的竞争企业，联繫地址，及策略性展望)

  • Arthrex Inc.
  • Seaspine Holdings Corporation
  • Sanofi
  • Bone Support
  • DePuy Synthes
  • Integra Lifesciences
  • Globus Medical Inc.
  • NuVasive Inc.
  • Terumo Corporation
  • Medtronic PLC
  • Stryker Corporation
  • Zimmer Biomet
  • Pioneer Surgical Technology
  • Smith & Nephew plc
  • Bioventus LLC
  • Orthofix, Inc.
  • Genzyme
  • Bone Biologics, Corp.
  • Osiris Therapeutics, Inc.
  • Other prominent players

第14章 主要策略性推荐事项

Product Code: BWC22155

Orthobiologics Market is Forecast to Touch USD 8.8 Billion by 2028

The global orthobiologics market is growing on account of the result of changing lifestyles and the rising rate of traffic and other forms of accidents along with the growing adoption of orthobiologics treatment among athletes…

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global orthobiologics market was worth USD 6.2 billion in the year 2021. It is estimated to grow at a CAGR of 5.20%, earning revenue of around USD 8.8 billion by the end of 2028. The global orthobiologics market is gaining significant traction owing to the rising incidence of broken bones and damaged muscles, tendons, and ligaments as a result of changing lifestyles and the rising rate of traffic and other forms of accidents, the market is booming. The growing adoption of orthobiologics among athletes is also propelling the industry forward. However, the high cost of global orthobiologics market may act as a major restraining factor for the market growth.

Rising Adoption of Orthobiologics in Sports Industry is Propelling Overall Market Growth

The frequency of broken bones and injured muscles are very common among athletes. However, longer resting periods can effectively sabotage the career of the athletes. Therefore, orthobiologics treatment is being suggested to them. This treatment is gaining huge traction in the sports industry. For instance, the American Medical Society for Sports Medicine (AMSSM) has released a position statement on Principles for the Responsible Use of Regenerative Medicine in Sports Medicine, which includes orthobiologics as well.

Increasing Demand for Orthopedic Surgery is Driving Orthobiologics Market

The demand for orthopedic surgery is increasing at a high rate owing to the rising demand for the treatment of musculoskeletal trauma, spine diseases, sports injuries, degenerative diseases, infections, tumors, and congenital disorders. The favorable reimbursement policies in first-world countries and low-cost treatment in emerging economies are significantly influencing the demand for orthopedic surgery. This is anticipated to fuel the demand for orthobiologics in the forecast period.

Orthobiologics Market - By End-User

Based on end-user, the orthobiologics market is segmented into hospitals, orthopedic clinics, & ambulatory care centers, research & academic institutes, dental clinics, and facilities. The hospitals, orthopedic clinics, & ambulatory care centers account for the largest market share. A key element contributing to the market share domination is the increasing acceptance of orthobiologic products in a wide range of spinal and reconstructive procedures conducted in hospitals. Furthermore, the availability of a wide range of orthobiologics products in hospitals also plays a crucial role in driving market growth.

Orthobiologics Market - Regional Insights

Geographically, the orthobiologics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. Because of its established healthcare infrastructure and high adoption of innovative treatment procedures in healthcare institutions, North America dominates the orthobiologics industry. Furthermore, the presence of major industry competitors as well as advantageous reimbursement policies is important factors in driving market expansion. However, the Asia-Pacific region is projected to witness the highest growth rate during the forecast period.

Impact of COVID-19 on Orthobiologics Market

The COVID-19 pandemic slowed the expansion of the orthobiologics sector dramatically. Due to limits on transportation and athletic activities, the risk of accidents decreased considerably as the countries implemented stringent lockdowns to prevent the virus from spreading. This has a direct influence on hospitals and other healthcare institutions' need for orthobiologics. The market was also constrained by limits in research and development operations, as the pharmaceutical industry's research focus turned to COVID-19 treatment and vaccine development.

Competitive Landscape

The leading market players of the orthobiologics market are Arthrex Inc., Seaspine Holdings Corporation, Sanofi, Bone Support, DePuy Synthes, Integra Lifesciences, Globus Medical Inc., NuVasive Inc., Terumo Corporation, Medtronic PLC, Stryker Corporation, Zimmer Biomet, Pioneer Surgical Technology, Smith & Nephew plc, Bioventus LLC, Orthofix, Inc., Genzyme, Bone Biologics, Corp., Osiris Therapeutics, Inc., and other prominent players.

The market is highly competitive with the presence of several multinational corporations and industrial giants. These companies significantly invest in research and development activities to introduce innovations into their offerings and are constantly launching new products. The adoption of competitive strategies such as partnerships, mergers, acquisitions, collaborations, etc., is also prominent in this market.

Don't miss the business opportunity of the orthobiologics market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the orthobiologics market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the orthobiologics market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Research
  • 2.2. Quantitative Research
  • 2.3. Market Breakdown & Data Triangulation
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary Research Respondents, By Region
  • 2.5. Assumption & Limitation

3. Executive Summary

4. Global Orthobiologics Market Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technological Landscape/Recent Development
  • 4.4. Regulatory Framework
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Intensity of Rivalry

5. Global Orthobiologics Market Overview

  • 5.1. Market Size & Forecast by Value, 2018-2028
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Demineralized Bone Matrix (DBM)
      • 5.2.1.2. Allograft
      • 5.2.1.3. Bone Morphogenetic Protein (BMP)
      • 5.2.1.4. Viscosupplementation Products
      • 5.2.1.5. Synthetic Bone Substitutes
      • 5.2.1.6. Others
    • 5.2.2. By Application
      • 5.2.2.1. Osteoarthritis & Degenerative Arthritis
      • 5.2.2.2. Spinal Fusion
      • 5.2.2.3. Fracture Recovery
      • 5.2.2.4. Soft Tissue Injuries
      • 5.2.2.5. Maxillofacial & Dental Applications
    • 5.2.3. By End User
      • 5.2.3.1. Hospitals & Ambulatory Centers
      • 5.2.3.2. Research & Academic Institute
      • 5.2.3.3. Dental Clinics
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. The Asia Pacific
      • 5.2.4.4. Latin America
      • 5.2.4.5. The Middle East and Africa

6. North America Orthobiologics Market

  • 6.1. Market Size & Forecast by Value, 2018-2028
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
      • 6.2.5.1. United States
      • 6.2.5.2. Canada

7. Europe Orthobiologics Market

  • 7.1. Market Size & Forecast by Value, 2018-2028
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
      • 7.2.5.1. Germany
      • 7.2.5.2. United Kingdom
      • 7.2.5.3. Italy
      • 7.2.5.4. France
      • 7.2.5.5. Spain
      • 7.2.5.6. Rest of Europe

8. The Asia Pacific Orthobiologics Market

  • 8.1. Market Size & Forecast by Value, 2018-2028
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
      • 8.2.5.1. China
      • 8.2.5.2. India
      • 8.2.5.3. Japan
      • 8.2.5.4. South Korea
      • 8.2.5.5. Rest of Asia Pacific

9. Latin America Orthobiologics Market

  • 9.1. Market Size & Forecast by Value, 2018-2028
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
      • 9.2.5.1. Brazil
      • 9.2.5.2. Mexico
      • 9.2.5.3. Rest of Latin America

10. The Middle East & Africa Orthobiologics Market

  • 10.1. Market Size & Forecast by Value, 2018-2028
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
  • 10.3. By Product
  • 10.4. By Type
  • 10.5. By Application
    • 10.5.1. By End User
    • 10.5.2. By Country
      • 10.5.2.1. Saudi Arabia
      • 10.5.2.2. UAE
      • 10.5.2.3. South Africa
      • 10.5.2.4. Rest of Middle East & Africa

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Market Share Analysis, 2021
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Development (Merger, Acquisition, Partnership.)

12. Impact of Covid-19 on Global Orthobiologics Market Industry

13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **

  • 13.1. Arthrex Inc.
  • 13.2. Seaspine Holdings Corporation
  • 13.3. Sanofi
  • 13.4. Bone Support
  • 13.5. DePuy Synthes
  • 13.6. Integra Lifesciences
  • 13.7. Globus Medical Inc.
  • 13.8. NuVasive Inc.
  • 13.9. Terumo Corporation
  • 13.10. Medtronic PLC
  • 13.11. Stryker Corporation
  • 13.12. Zimmer Biomet
  • 13.13. Pioneer Surgical Technology
  • 13.14. Smith & Nephew plc
  • 13.15. Bioventus LLC
  • 13.16. Orthofix, Inc.
  • 13.17. Genzyme
  • 13.18. Bone Biologics, Corp.
  • 13.19. Osiris Therapeutics, Inc.
  • 13.20. Other prominent players

14. Key Strategic Recommendations

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List of Figures

  • Figure 1 Global Orthobiologics Market Segmentation
  • Figure 2 Global Orthobiologics Market Value Chain Analysis
  • Figure 3 Company Market Share Analysis, 2021
  • Figure 4 Global Orthobiologics Market Size, By Value (USD Million), 2018-2028
  • Figure 5 Global Orthobiologics Market Share, By Product, By Value, 2018-2028
  • Figure 6 Global Orthobiologics Market Share, By Type, By Value, 2018-2028
  • Figure 7 Global Orthobiologics Market Share, By Application, By Value, 2018-2028
  • Figure 8 Global Orthobiologics Market Share, By End User, By Value, 2018-2028
  • Figure 9 Global Orthobiologics Market Share, By Region, By Value, 2018-2028
  • Figure 10 North America Orthobiologics Market Size, By Value (USD Million), 2018-2028
  • Figure 11 North America Orthobiologics Market Share, By Product, By Value, 2018-2028
  • Figure 12 North America Orthobiologics Market Share, By Type, By Value, 2018-2028
  • Figure 13 North America Orthobiologics Market Share, By Application, By Value, 2018-2028
  • Figure 14 North America Orthobiologics Market Share, By End User, By Value, 2018-2028
  • Figure 15 North America Orthobiologics Market Share, By Country, By Value, 2018-2028
  • Figure 16 Europe Orthobiologics Market Size, By Value (USD Million), 2018-2028
  • Figure 17 Europe Orthobiologics Market Share, By Product, By Value, 2018-2028
  • Figure 18 Europe Orthobiologics Market Share, By Type, By Value, 2018-2028
  • Figure 19 Europe Orthobiologics Market Share, By Application, By Value, 2018-2028
  • Figure 20 Europe Orthobiologics Market Share, By End User, By Value, 2018-2028
  • Figure 21 Europe Orthobiologics Market Share, By Country, By Value, 2018-2028
  • Figure 22 The Asia-Pacific Orthobiologics Market Size, By Value (USD Million), 2018-2028
  • Figure 23 The Asia-Pacific Orthobiologics Market Share, By Product, By Value, 2018-2028
  • Figure 24 The Asia-Pacific Orthobiologics Market Share, By Type, By Value, 2018-2028
  • Figure 25 The Asia-Pacific Orthobiologics Market Share, By Application, By Value, 2018-2028
  • Figure 26 The Asia-Pacific Orthobiologics Market Share, By End User, By Value, 2018-2028
  • Figure 27 The Asia-Pacific Orthobiologics Market Share, By Country, By Value, 2018-2028
  • Figure 28 Latin America Orthobiologics Market Size, By Value (USD Million), 2018-2028
  • Figure 29 Latin America Orthobiologics Market Share, By Product, By Value, 2018-2028
  • Figure 30 Latin America Orthobiologics Market Share, By Type, By Value, 2018-2028
  • Figure 31 Latin America Orthobiologics Market Share, By Application, By Value, 2018-2028
  • Figure 32 Latin America Orthobiologics Market Share, By End User, By Value, 2018-2028
  • Figure 33 Latin America Orthobiologics Market Share, By Country, By Value, 2018-2028
  • Figure 34 The Middle East & Africa Orthobiologics Market Size, By Value (USD Million), 2018-2028
  • Figure 35 The Middle East & Africa Orthobiologics Market Share, By Product, By Value, 2018-2028
  • Figure 36 The Middle East & Africa Orthobiologics Market Share, By Type, By Value, 2018-2028
  • Figure 37 The Middle East & Africa Orthobiologics Market Share, By Application, By Value, 2018-2028
  • Figure 38 The Middle East & Africa Orthobiologics Market Share, By End User, By Value, 2018-2028
  • Figure 39 The Middle East & Africa Orthobiologics Market Share, By Country, By Value, 2018-2028

List of Tables

  • Table 1 Global Orthobiologics Market Size, By Product, By Value, 2018-2028
  • Table 2 Global Orthobiologics Market Size, By Type, By Value, 2018-2028
  • Table 3 Global Orthobiologics Market Size, By Application, By Value, 2018-2028
  • Table 4 Global Orthobiologics Market Size, By End User, By Value, 2018-2028
  • Table 5 Global Orthobiologics Market Size, By Region, By Value, 2018-2028
  • Table 6 North America Orthobiologics Market Size, By Product, By Value, 2018-2028
  • Table 7 North America Orthobiologics Market Size, By Type, By Value, 2018-2028
  • Table 8 North America Orthobiologics Market Size, By Application, By Value, 2018-2028
  • Table 9 North America Orthobiologics Market Size, By End User, By Value, 2018-2028
  • Table 10 North America Orthobiologics Market Size, By Country, By Value, 2018-2028
  • Table 11 Europe Orthobiologics Market Size, By Product, By Value, 2018-2028
  • Table 12 Europe Orthobiologics Market Size, By Type, By Value, 2018-2028
  • Table 13 Europe Orthobiologics Market Size, By Application, By Value, 2018-2028
  • Table 14 Europe Orthobiologics Market Size, By End User, By Value, 2018-2028
  • Table 15 Europe Orthobiologics Market Size, By Country, By Value, 2018-2028
  • Table 16 The Asia-Pacific Orthobiologics Market Size, By Product, By Value, 2018-2028
  • Table 17 The Asia-Pacific Orthobiologics Market Size, By Type, By Value, 2018-2028
  • Table 18 The Asia-Pacific Orthobiologics Market Size, By Application, By Value, 2018-2028
  • Table 19 The Asia-Pacific Orthobiologics Market Size, By End User, By Value, 2018-2028
  • Table 20 The Asia-Pacific Orthobiologics Market Size, By Country, By Value, 2018-2028
  • Table 21 Latin America Orthobiologics Market Size, By Product, By Value, 2018-2028
  • Table 22 Latin America Orthobiologics Market Size, By Type, By Value, 2018-2028
  • Table 23 Latin America Orthobiologics Market Size, By Application, By Value, 2018-2028
  • Table 24 Latin America Orthobiologics Market Size, By End User, By Value, 2018-2028
  • Table 25 Latin America Orthobiologics Market Size, By Country, By Value, 2018-2028
  • Table 26 The Middle East & Africa Orthobiologics Market Size, By Product, By Value, 2018-2028
  • Table 27 The Middle East & Africa Orthobiologics Market Size, By Type, By Value, 2018-2028
  • Table 28 The Middle East & Africa Orthobiologics Market Size, By Application, By Value, 2018-2028
  • Table 29 The Middle East & Africa Orthobiologics Market Size, By End User, By Value, 2018-2028
  • Table 30 The Middle East & Africa Orthobiologics Market Size, By Country, By Value, 2018-2028
  • Table 31 Arthrex Inc. Company Overview
  • Table 32 Arthrex Inc. Financial Overview
  • Table 33 Seaspine Holdings Corporation Company Overview
  • Table 34 Seaspine Holdings Corporation Financial Overview
  • Table 35 Sanofi Company Overview
  • Table 36 Sanofi Financial Overview
  • Table 37 Bone Support Company Overview
  • Table 38 Bone Support Financial Overview
  • Table 39 DePuy Synthes Company Overview
  • Table 40 DePuy Synthes Financial Overview
  • Table 41 Integra Lifesciences Company Overview
  • Table 42 Integra Lifesciences Financial Overview
  • Table 43 NuVasive Inc. Company Overview
  • Table 44 NuVasive Inc. Financial Overview
  • Table 45 Globus Medical Inc. Company Overview
  • Table 46 Globus Medical Inc. Financial Overview
  • Table 47 Terumo Corporation Company Overview
  • Table 48 Terumo Corporation Financial Overview
  • Table 49 Medtronic PLC Company Overview
  • Table 50 Medtronic PLC Financial Overview
  • Table 51 Stryker Corporation Company Overview
  • Table 52 Stryker Corporation Financial Overview
  • Table 53 Zimmer Biomet Company Overview
  • Table 54 Zimmer Biomet Financial Overview
  • Table 55 Pioneer Surgical Technology Company Overview
  • Table 56 Pioneer Surgical Technology Financial Overview
  • Table 57 Smith & Nephew plc Company Overview
  • Table 58 Smith & Nephew plc Financial Overview
  • Table 59 Bioventus LLC Company Overview
  • Table 60 Bioventus LLC Financial Overview
  • Table 61 Orthofix Company Overview
  • Table 62 Orthofix Financial Overview
  • Table 63 Genzyme Company Overview
  • Table 64 Genzyme Financial Overview
  • Table 65 Bone Biologics, Corp. Company Overview
  • Table 66 Bone Biologics, Corp. Financial Overview
  • Table 67 Osiris Therapeutics Company Overview
  • Table 68 Osiris Therapeutics Financial Overview